We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Generac Holdings
GNRC
$11.9B
| $8.49M | 0.01% |
208,301
-48,310
| -19% | -$1.91M |
|
|
FBRC
427
DELISTED
FBR & Co. Common Stock
FBRC
| $8.34M | 0.01% |
641,647
+15,992
| +3% | +$207K |
|
|
TOWR
428
DELISTED
Tower International, Inc.
TOWR
| $8.29M | 0.01% |
292,440
+7,918
| +3% | +$199K |
|
429
GE Aerospace
GE
$367B
| $8.25M | 0.01% |
54,493
-306,299
| -85% | -$44.5M |
|
|
430
Occidental Petroleum
OXY
$57B
| $8.1M | 0.01% |
113,655
-6,911,574
| -98% | -$491M |
|
|
SRG
431
Seritage Growth Properties
SRG
$130M
| $7.95M | 0.01% |
186,110
+39,810
| +27% | +$1.85M |
|
432
Winnebago Industries
WGO
$870M
| $7.88M | 0.01% |
248,831
+6,775
| +3% | +$211K |
|
|
XCRA
433
DELISTED
Xcerra Corporation
XCRA
| $7.79M | 0.01% |
1,019,124
-334,240
| -25% | -$2.16M |
|
|
BBG
434
DELISTED
Bill Barrett Corp
BBG
| $7.74M | 0.01% |
1,107,167
+436,637
| +65% | +$2.79M |
|
435
Goodyear
GT
$2.07B
| $7.69M | 0.01% |
249,000
| – | – |
|
436
IBM
IBM
$202B
| $7.65M | 0.01% |
48,205
-6,090
| -11% | -$928K |
|
437
Royal Caribbean
RCL
$78.7B
| $7.63M | 0.01% |
93,000
| – | – |
|
|
ISCA
438
DELISTED
International Speedway Corp
ISCA
| $7.52M | 0.01% |
204,324
-181,657
| -47% | -$6.38M |
|
439
CNO Financial Group
CNO
$4.97B
| $7.43M | 0.01% |
388,135
-88,930
| -19% | -$1.53M |
|
440
Kearny Financial
KRNY
$592M
| $7.4M | 0.01% |
475,937
-8,510
| -2% | -$125K |
|
|
CGI
441
DELISTED
Celadon Group Inc
CGI
| $7.33M | 0.01% |
1,025,240
+388,994
| +61% | +$2.93M |
|
|
FFIC
442
DELISTED
Flushing Financial
FFIC
| $7.25M | 0.01% |
246,702
+3,641
| +1% | +$92.5K |
|
443
Alerian MLP ETF
AMLP
$13B
| $7.01M | 0.01% |
111,240
| – | – |
|
444
AdvanSix
ASIX
$567M
| $7.01M | 0.01% |
+316,543
| New | +$5.69M |
|
445
Silvercrest Asset Management
SAMG
$76.4M
| $6.9M | 0.01% |
524,516
+9,755
| +2% | +$122K |
|
|
ATSG
446
DELISTED
Air Transport Services Group
ATSG
| $6.82M | 0.01% |
427,050
-27,770
| -6% | -$429K |
|
447
Aecom
ACM
$9.07B
| $6.73M | 0.01% |
185,145
-116,005
| -39% | -$3.85M |
|
448
Qualcomm
QCOM
$176B
| $6.72M | 0.01% |
103,035
+98,800
| +2,333% | +$6.64M |
|
449
Ares Capital
ARCC
$13.5B
| $6.68M | 0.01% |
405,286
-20,716
| -5% | -$326K |
|
450
Fresenius Medical Care
FMS
$13.2B
| $6.63M | 0.01% |
157,041
-8,462
| -5% | -$345K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.